BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q4 2025

Type / Class
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
Symbol
BNTX on Nasdaq
Shares outstanding
239,647,920
Price per share
$116.77
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
47,648,640
Total reported value
$4,535,991,673
% of total 13F portfolios
0%
Share change
-4,593,540
Value change
-$445,147,474
Number of holders
276
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Medine GmbH 18% $4,386,515,536 42,178,034 Prof. Ugur Sahin, M.D. 31 Mar 2025

As of 31 Dec 2025, 276 institutional investors reported holding 47,648,640 shares of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX). This represents 20% of the company’s total 239,647,920 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) together control 16% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 2.5% 5,933,594 +8.8% 0.03% $564,878,131
T. Rowe Price Investment Management, Inc. 1.9% 4,484,599 -7.2% 0.27% $426,934,000
FLOSSBACH VON STORCH SE 1.8% 4,196,048 -0.8% 1.6% $399,463,770
PRIMECAP MANAGEMENT CO/CA/ 1.6% 3,800,011 -1.8% 0.27% $361,761,047
Dodge & Cox 1.5% 3,614,491 -0.89% 0.19% $344,099,543
BNP PARIBAS FINANCIAL MARKETS 0.66% 1,578,094 0% 0.1% $150,234,549
Temasek Holdings (Private) Ltd 0.63% 1,506,027 0% 0.46% $143,373,770
JANE STREET GROUP, LLC 0.57% 1,361,221 +591% 0.15% $129,588,239
BAILLIE GIFFORD & CO 0.52% 1,244,867 -84% 0.1% $118,511,339
BlackRock, Inc. 0.48% 1,152,884 +51% 0% $109,754,540
Capital International Investors 0.47% 1,134,941 -0.01% 0.02% $108,046,383
GSK plc 0.37% 889,824 0% 11% $84,711,245
BANK OF AMERICA CORP /DE/ 0.31% 736,597 +28% 0.01% $70,124,035
MORGAN STANLEY 0.28% 680,669 +13% 0% $64,799,832
CITADEL ADVISORS LLC 0.28% 678,175 +74% 0.04% $64,562,260
Candriam S.C.A. 0.25% 604,916 +2.6% 0.29% $57,590,455
FRANKLIN RESOURCES INC 0.24% 577,900 -21% 0.01% $55,015,819
Long Focus Capital Management, LLC 0.21% 507,655 +28% 2.5% $48,328,756
D. E. Shaw & Co., Inc. 0.2% 488,552 0.04% $46,510,150
DekaBank Deutsche Girozentrale 0.2% 481,397 0% 0.1% $46,397,000
TANG CAPITAL MANAGEMENT LLC 0.2% 470,000 +74% 2.2% $44,744,000
DEUTSCHE BANK AG\ 0.19% 446,283 +17% 0.01% $42,486,142
VOLORIDGE INVESTMENT MANAGEMENT, LLC 0.18% 437,565 0.15% $41,656,188
VICTORY CAPITAL MANAGEMENT INC 0.17% 400,593 -3.2% 0.02% $38,136,454
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 0.17% 400,382 -13% 0.03% $38,093,046

Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 47,648,640 $4,535,991,673 -$445,147,474 $95.20 276
2025 Q3 50,481,130 $4,974,375,396 -$319,748,638 $98.62 253
2025 Q2 53,756,637 $5,723,405,583 +$241,986,249 $106.47 255
2025 Q1 51,766,102 $4,713,883,792 +$16,375,983 $91.06 276
2024 Q4 50,762,221 $5,785,970,647 +$270,315,091 $113.95 299
2024 Q3 44,146,673 $5,240,957,854 +$448,042,220 $118.77 288
2024 Q2 40,965,872 $3,292,084,415 -$3,371,001 $80.36 278
2024 Q1 40,861,236 $3,768,152,227 +$21,661,779 $92.25 278
2023 Q4 40,542,745 $4,273,885,983 +$369,420,974 $105.54 277
2023 Q3 36,919,967 $4,008,689,944 -$40,677,233 $108.64 245
2023 Q2 37,381,433 $4,042,183,779 -$207,319,966 $107.93 246
2023 Q1 39,079,137 $4,865,003,807 -$130,605,071 $124.57 272
2022 Q4 39,706,670 $5,966,384,929 +$387,882,980 $150.22 312
2022 Q3 37,131,368 $5,008,892,299 +$489,942,648 $134.88 249
2022 Q2 33,416,255 $4,980,080,985 -$212,346,370 $149.10 276
2022 Q1 34,519,697 $5,890,695,868 -$225,320,254 $170.56 274
2021 Q4 35,195,775 $9,066,882,359 -$433,429,701 $257.80 334
2021 Q3 36,667,998 $10,011,251,135 +$781,975,407 $272.99 328
2021 Q2 33,709,299 $7,548,281,316 +$1,380,454,495 $223.88 275
2021 Q1 29,716,757 $3,242,039,601 +$922,839,812 $109.19 213
2020 Q4 20,695,182 $1,688,417,367 -$282,174,671 $81.52 183
2020 Q3 24,274,421 $1,679,824,791 -$160,429,955 $69.23 144
2020 Q2 26,613,030 $1,776,088,789 +$1,335,873,540 $66.74 108
2020 Q1 6,620,182 $383,744,138 -$108,916,451 $58.40 36
2019 Q4 8,476,761 $285,550,000 +$285,550,000 $33.88 19